Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) have been given an average recommendation of “Hold” by the eighteen brokerages that are currently covering the company, Marketbeat reports. Eleven research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $11.50.
A number of analysts recently weighed in on TDOC shares. Bank of America boosted their target price on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. The Goldman Sachs Group boosted their target price on Teladoc Health from $14.00 to $16.00 and gave the stock a “buy” rating in a research report on Tuesday, February 18th. Barclays boosted their target price on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 price target (up from $11.00) on shares of Teladoc Health in a research note on Wednesday, December 4th. Finally, Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th.
View Our Latest Analysis on TDOC
Insider Transactions at Teladoc Health
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in the company. Vise Technologies Inc. lifted its stake in shares of Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider’s stock valued at $274,000 after purchasing an additional 1,405 shares during the period. PharVision Advisers LLC purchased a new position in shares of Teladoc Health in the 4th quarter valued at approximately $301,000. Twinbeech Capital LP lifted its stake in shares of Teladoc Health by 63.8% in the 4th quarter. Twinbeech Capital LP now owns 382,735 shares of the health services provider’s stock valued at $3,479,000 after purchasing an additional 149,118 shares during the period. Two Sigma Advisers LP lifted its stake in shares of Teladoc Health by 213.0% in the 4th quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock valued at $20,532,000 after purchasing an additional 1,537,094 shares during the period. Finally, Two Sigma Investments LP purchased a new position in Teladoc Health during the fourth quarter valued at $18,348,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.
Teladoc Health Stock Down 1.8 %
Shares of NYSE TDOC opened at $11.18 on Friday. The business has a 50-day moving average of $10.58 and a 200-day moving average of $9.52. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of -1.94 and a beta of 1.04. Teladoc Health has a 12 month low of $6.76 and a 12 month high of $15.95. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
- Five stocks we like better than Teladoc Health
- What is the MACD Indicator and How to Use it in Your Trading
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Investing In Preferred Stock vs. Common Stock
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.